Taysha, UTSW start fund to speed up CNS gene therapies

By The Science Advisory Board staff writers

January 13, 2021 -- Taysha Gene Therapies and the University of Texas Southwestern Medical Center (UTSW) have launched a fund to accelerate the development of adeno-associated virus (AAV) gene therapies for monogenic diseases of the central nervous system (CNS).

Expanding this partnership supports the medical center's discovery efforts to bring about promising therapies while Taysha gets an exclusive option on new programs and intellectual property linked to this deal.

Copyright © 2021 scienceboard.net

To read this and get access to all of the exclusive content on The Science Advisory Board create a free account or sign-in now.

Member Sign In:
MemberID or email address:  
Do you have a Scienceboard.net password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?